论文信息 - Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.

Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.

We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.